PER percheron therapeutics limited

Ann: Quarterly Activities Report and Appendix 4C, page-84

  1. 8,333 Posts.
    lightbulb Created with Sketch. 831
    Well I think Garner is the right mix of well spoken engaged CEO and experienced bio-tech professional and he has surrounded himself with good experience, and another person to come after the vote. For a micro-cap vehicle this is extremely valuable. Yes, KZA and PER have turned out to be disappointing for Garner , but PER is now the his/teams first chance to create something totally in their own image.

    The comsec brigade was buying yesterday , no obvious signs of Gennadi BUYING the vote anyways. But lets see if any Sub changes today

    1.4 is pretty obvious resistance and coincides with my estimate of cash backing , but I could see it see it hitting 3 cents if it wants to, seems fair value for a vehicle with a lot of cash and a strong team, but may need to wait til after the vote.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.9¢
Change
0.000(0.00%)
Mkt cap ! $9.786M
Open High Low Value Volume
0.9¢ 0.9¢ 0.9¢ $1.62K 180K

Buyers (Bids)

No. Vol. Price($)
4 364826 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 8026021 8
View Market Depth
Last trade - 10.37am 25/07/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.